New England Private Wealth Advisors LLC Pfizer Inc Transaction History

New England Private Wealth Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $589,695 - $669,229	-17,913 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $1,364 - $1,769	42 Added 0.24%	17,913 $644,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $76,215 - $85,572	-2,061 Reduced 10.34%	17,871 $775,000
Q1 2019 May 02, 2019	BUY	$37.5 - $41.2 $31,050 - $34,113	828 Added 4.33%	19,932 $845,000
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $104,253 - $118,860	2,710 Added 16.53%	19,104 $832,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $29,196 - $35,413	-847 Reduced 4.91%	16,394 $724,000
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $824 - $878	25 Added 0.15%	17,241 $628,000
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $48,630 - $56,418	1,524 Added 9.71%	17,216 $612,000
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $18,392 - $19,515	-553 Reduced 3.4%	15,692 $568,000
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $503,595 - $554,766	16,245	16,245 $578,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of New England Private Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on New England Private Wealth Advisors LLC with notifications on news.